Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| p53 signaling pathway | R-HSA-168638 | map04115 | methocarbamol | 222284 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | methocarbamol | 222284 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | methocarbamol | 222284 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | methocarbamol | 222284 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | methocarbamol | 222284 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | PHA-00767505E | None | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | PHA-00767505E | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | PHA-00767505E | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | PHA-00767505E | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | PHA-00767505E | None | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | PHA-00767505E | None | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | PHA-00767505E | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | PHA-00767505E | None | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | PHA-00767505E | None | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | PHA-00767505E | None | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | PHA-00767505E | None | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | PHA-00767505E | None | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | PHA-00767505E | None | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | PHA-00767505E | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | PHA-00767505E | None | drug-path |